The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Sex and racial differences in bladder cancer presentation and mortality in the US
Abstract
BACKGROUD: Sex, race, and age at diagnosis have a significant impact on mortality from bladder cancer (BC). Women, African Americans of both sexes, and the elderly, all experience higher mortality rates. Tumor grade, stage, and histologic type at presentation also affect outcome. To determine whether age and tumor characteristics alone explain the excess hazard of death from BC observed in some demographic groups, the authors queried the Surveillance, Epidemiology, and End Results (SEER) limited‐use database for the presentations of and outcomes from BC between 1990 and 2005. METHODS: Tumors were characterized by grade, stage, and histologic type. Hazards rates for BC‐specific mortality were compared by race and sex using a piecewise Cox regression model, adjusting for factors (age, stage, grade, and histologic type) that differed significantly between the groups that were compared. RESULTS: Excess hazard of death from BC was present during the first 2 to 3 years of follow‐up among women and during the first 4 years of follow‐up among African Americans. Adjustment for age and tumor characteristics eliminated approximately 30% of this excess hazard in sex comparison among whites. In sex comparison among blacks and in racial comparisons within each sex, approximately 50% to 70% of excess hazard could be eliminated by adjustment. CONCLUSIONS: Significant differences in tumor characteristics and age at presentation did not fully account for the excess hazard of death from BC among women and African Americans. Other factors, such as choice and efficacy of therapies, differences within a given tumor characteristic group, and/or host factors, also may play important roles. Cancer 2009. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
Epidemiology: Beyond the Basics
Szklo, M., & Nieto, F. J. (1999) · Cited by 1,441
Epidemiology: Beyond the Basics
Szklo, M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.8.821 · Cited by 1,310
The Analysis of Failure Times in the Presence of Competing Risks
Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., & Breslow, N. E. (1978) · Biometrics · doi:10.2307/2530374 · Cited by 1,266
Applied Survival Analysis: Regression Modeling of Time to Event Data
Rao, P. V., Hosmer, D. W., & Lemeshow, S. (2000) · Journal of the American Statistical Association · doi:10.2307/2669422 · Cited by 861
The health economics of bladder cancer: A comprehensive review of the published literature
Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., & Hauser, R. (2003) · PharmacoEconomics · doi:10.1007/bf03262330 · Cited by 860
Analysing Survival Data From Clinical Trials and Observational Studies
(1996) · Technometrics · doi:10.1080/00401706.1996.10484530 · Cited by 663
The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
Stenzl, A., Cowan, N. C., De Santis, M., Jakse, G., Kuczyk, M. A., Merseburger, A. S., Ribal, M. J., Sherif, A., & Witjes, J. A. (2009) · European Urology · doi:10.1016/j.eururo.2009.01.002 · Cited by 639
Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program
Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-541 · Cited by 487
Modelling Survival Data in Medical Research
(2004) · Technometrics · doi:10.1198/tech.2004.s817 · Cited by 430
Kochanek, K. D., Murphy, S. L., Anderson, R. N., & Scott, C. (2004) · PubMed · Cited by 382
Modelling Survival Data in Medical Research (2nd ed.) (Book)
Cowles, M. K. (2004) · Quarterly Publications of the American Statistical Association · Cited by 369
Analysing Survival Data from Clinical Trials and Observational Studies
Ziegel, E. R., Marubini, E., & Valsecchi, M. (1996) · Technometrics · doi:10.2307/1270634 · Cited by 260
The National Cancer Data Base report on bladder carcinoma
Fleshner, N. E., Herr, H. W., Stewart, A. K., Murphy, G. P., Mettlin, C. J., & Menck, H. R. (1996) · Cancer · Cited by 170
Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program
Konety, B. R., & Joslyn, S. A. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000091620.86778.2e · Cited by 144
Regression Models and Non-Proportional Hazards in the Analysis of Breast Cancer Survival
Gore, S. M., Pocock, S., & Kerr, G. R. (1984) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2347444 · Cited by 144
Adherence to Surveillance Among Patients With Superficial Bladder Cancer
Schrag, D., Hsieh, L. J., Rabbani, F., Bach, P. B., Herr, H. W., & Begg, C. B. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.588 · Cited by 143
Epidemiological research methods
(1997) · Choice Reviews Online · doi:10.5860/choice.35-0342 · Cited by 95
Urinary tract infections and reduced risk of bladder cancer in Los Angeles
Jiang, X., Castelao, J. E., Groshen, S. G., Cortessis, V. K., Shibata, D. K., Conti, D. V., Yuan, J.-M., Pike, M. C., & Gago-Domínguez, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604889 · Cited by 59
Racial disparities in resource utilization for cystectomy
Taub, D. A., Hollenbeck, B. K., Cooper, K. L., Dunn, R. L., Miller, D. C., Taylor, J. M. G., & Wei, J. T. (2006) · Urology · doi:10.1016/j.urology.2005.09.003 · Cited by 51
Stage as major long term outcome predictor in minor salivary gland carcinoma
Lutgendorf (2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20000915)89:6 · Cited by 1
Cited by
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
Dobruch, J., Daneshmand, S., Fisch, M., Lotan, Y., Noon, A. P., Resnick, M. J., Shariat, S. F., Zlotta, A. R., & Boorjian, S. A. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.037 · Cited by 673
Sex Disparities in Cancer Mortality and Survival
Cook, M. B., McGlynn, K. A., Devesa, S. S., Freedman, N. D., & Anderson, W. F. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0246 · Cited by 515
Gakis, G., Efstathiou, J., Lerner, S. P., Cookson, M. S., Keegan, K. A., Guru, K. A., Shipley, W. U., Heidenreich, A., Schoenberg, M. P., Sagaloswky, A. I., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.08.009 · Cited by 422
van Hoogstraten, L. M. C., Vrieling, A., van der Heijden, A. G., Kogevinas, M., Richters, A., & Kiemeney, L. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00744-3 · Cited by 375
Epidemiology, Screening, and Prevention of Bladder Cancer
Lobo, N., Afferi, L., Moschini, M., Mostafid, H., Porten, S., Psutka, S. P., Gupta, S., Smith, A. B., Williams, S. B., & Lotan, Y. (2022) · European Urology Oncology · doi:10.1016/j.euo.2022.10.003 · Cited by 372
Metadata
- Authors
- Scosyrev, E., Noyes, K., Feng, C., & Messing, E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-12-29
- Volume
- 115
- Issue
- 1
- Pages
- 68-74
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2138312679
- Cited by
- 308
- References
- 22
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.